COLL Initiated Coverage by Leerink Partners -- Rating Set to Outperform

gurufocus.com · 2026-09-09

Collegium Pharmaceutical (COLL) Analyst Rating Update On October 19, 2023, Leerink Partners initiated coverage on Collegium Pharmaceutical (COLL) with an Out

TickrTrends take: Leerink Partners' initiation of coverage with an Outperform rating provides third-party validation that may support COLL's current Undervalued designation on TickrTrends. As a Healthcare sector company receiving positive analyst attention, the stock could attract value-oriented investors if the market has previously overlooked the company's prospects. Investors focused on valuation metrics should monitor whether this analyst coverage narrows any gap between the market price and fundamental value indicators that underpin the Undervalued assessment.

Read the full story at gurufocus.com →